Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. From Wikipedia
Regulators warn the merger would unite the only two U.S. clinical trial leaders in TAVR-AR, threatening innovation and raising treatment costs.
